News >

Rosenberg Sees New Milestone in Latest CAR Findings

Anita T. Shaffer @Shaffer1
Published: Tuesday, Sep 09, 2014

Dr Steven Rosenberg

Steven A. Rosenberg, MD, PhD

A recent study involving a chimeric antigen receptor (CAR) therapy represents a new milestone in the development of this emerging class of immunotherapies because it marks the first time that the approach has demonstrated efficacy in patients with aggressive B-cell malignancies, according to a leading investigator.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: New Directions in Advanced Cutaneous Squamous Cell Carcinoma: Emerging Evidence of ImmunotherapyAug 13, 20191.5
Publication Bottom Border
Border Publication
x